Comparing CT and MRI scans for mouth and throat cancer
Part of Cancer clinical trials.
This trial compares two types of scans—dual-energy CT and MRI—to see which is better at evaluating squamous cell cancers of the mouth or throat. It is for patients who have already had both scans as part of their care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with squamous cell carcinoma of the mouth or the back of the throat (the oropharynx), confirmed by a biopsy
- You have already had a clinical exam with a scope (nasofibroscopy) done by an ear, nose, and throat surgeon
- You have already had a contrast-enhanced MRI of your head and neck
- You have already had a contrast-enhanced dual-energy CT scan of your head and neck with a special maneuver called BOLT
- You do not have cancer of the lip, and you do not have any reason you cannot have one or both of the imaging tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of imaging for dental and facial problems: a dental MRI (which uses magnets and no radiation) and a low-dose CBCT scan (a type of X-ray). If you have a face or mouth condition affecting soft tissue, or if you are a healthy volunteer, you may be able to help us see if MRI can replace the need for radiation-based scans.
This trial uses repeated MRI scans to better predict which patients may develop painful jaw and mouth tissue problems after radiation and/or certain bone or blood-vessel medicines. It may help clinicians spot problems earlier and tailor follow-up care.
This study uses repeat MRI scans to look for imaging “markers” that may help doctors better understand head and neck squamous cell cancer. It may be most relevant if you are planning curative surgery and/or (chemo)radiotherapy and can safely undergo MRI more than once.
This study looks at how well two tests, a blood test (ctDNA) and an MRI scan, can track head and neck cancer during and after standard treatment with radiation and chemotherapy. It aims to improve how treatment response is measured.
This trial compares two ways of checking whether early oral cavity squamous cell cancer has spread to neck lymph nodes. It tests whether sentinel lymph node biopsy can find spread as well as standard neck dissection, while potentially reducing more extensive surgery for some people.
This study uses a combined PET/MR scan to better look at head and neck squamous cell cancer before or during treatment. It may help doctors see where the cancer is and how far it has spread, to support planning for curative radiation treatment.
Hear when a new Oral Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.